Genzyme Corp - Strategic SWOT Analysis Review

Date: February 15, 2017
Pages: 34
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: GC63D4CCD04EN
Leaflet:

Download PDF Leaflet

Genzyme Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty treatments targeting rare and special unmet medical needs. Its product pipeline comprises Dupilumab for atopic dermatitis and asthma; Patisiran for familial amyloid polyneuropathy; Isatuximab for multiple myeloma; and Fitisuran for Hemophilia, among others. The company primarily focuses on rare genetic disorders, kidney diseases, orthopedics, organ transplant, cancer, and immune disease. Genzyme also develops products for the treatment of cardiovascular diseases, neurodegenerative diseases and other areas. It operates a research and development lab and manufacturing plants in the US, Belgium and Ireland. The company has presence in the Americas, Europe, Asia-Pacific, Middle East and Africa. Genzyme is headquartered in Massachusetts, the US.

Genzyme Corp Key Recent Developments

Feb 09, 2017: Sanofi Genzyme Commitment to Patients with Rare Diseases Highlighted at WORLDSymposium 2017.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

Genzyme Corp - Key Facts
Genzyme Corp - Key Employees
Genzyme Corp - Key Employee Biographies
Genzyme Corp - Major Products and Services
Genzyme Corp - Pharmaceutical Pipeline Products Data
Genzyme Corp, Pipeline Products by Therapy Area
Genzyme Corp, Pipeline Products by Development Phase
Genzyme Corp - History
Genzyme Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Genzyme Corp - Business Description
Genzyme Corp - Corporate Strategy
Genzyme Corp - SWOT Analysis
SWOT Analysis - Overview
Genzyme Corp - Strengths
Genzyme Corp - Weaknesses
Genzyme Corp - Opportunities
Genzyme Corp - Threats
Genzyme Corp - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Genzyme Corp, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Feb 09, 2017: Sanofi Genzyme Commitment to Patients with Rare Diseases Highlighted at WORLDSymposium 2017

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Genzyme Corp, Key Facts
Genzyme Corp, Key Employees
Genzyme Corp, Key Employee Biographies
Genzyme Corp, Major Products and Services
Genzyme Corp, Number of Pipeline Products by Therapy Area
Genzyme Corp, Number of Pipeline Products by Development Stage
Genzyme Corp, History
Genzyme Corp, Other Locations
Genzyme Corp, Subsidiaries
Genzyme Corp, Joint Venture
Genzyme Corp, Key Competitors
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Genzyme Corp, Recent Deals Summary 31

LIST OF FIGURES

Genzyme Corp, Pipeline Products by Therapy Area
Genzyme Corp, Pipeline Products by Development Phase
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Genzyme Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

LIST OF TABLES

Genzyme Corp, Key Facts
Genzyme Corp, Key Employees
Genzyme Corp, Key Employee Biographies
Genzyme Corp, Major Products and Services
Genzyme Corp, Number of Pipeline Products by Therapy Area
Genzyme Corp, Number of Pipeline Products by Development Stage
Genzyme Corp, History
Genzyme Corp, Other Locations
Genzyme Corp, Subsidiaries
Genzyme Corp, Joint Venture
Genzyme Corp, Key Competitors
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Genzyme Corp, Recent Deals Summary 31

LIST OF FIGURES

Genzyme Corp, Pipeline Products by Therapy Area
Genzyme Corp, Pipeline Products by Development Phase
Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Genzyme Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Skip to top


Ask Your Question

Genzyme Corp - Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: